RSV
-
PublishedDecember 19, 2022
Children’s medicine shortage hits as flu season starts fast
Doctors and other experts say the problem could persist through the winter cold-and-flu season but should not last as long as other recent shortages of baby formula.
-
PublishedDecember 15, 2022
RSV continues to bulldoze Midcoast schools, causing teachers to call out sick
Kate Furbish Elementary in Brunswick closed last week after several staff members apparently contracted RSV, COVID-19 and influenza; Morse High School was closed Friday, Dec. 16, due to high absence among staff.
-
PublishedDecember 7, 2022
Face masks may return amid holiday ‘tripledemic’ of COVID, flu and RSV
-
PublishedDecember 6, 2022
Midcoast schools close for deep cleaning after outbreak of respiratory illness
Dozens of students in Topsham and Harpswell have contracted a virus believed to be RSV.
-
PublishedDecember 6, 2022
Influenza cases in Maine doubled in the last week
Maine recorded 1,720 new cases of influenza during the week ending Dec. 2, and flu-related hospitalizations nearly quadrupled from the previous week, going from 17 to 63.
-
PublishedDecember 4, 2022
RSV may be peaking in Maine, but flu hospitalizations are on the rise
Maine is seeing an increase in influenza cases and hospitalizations.
-
PublishedDecember 1, 2022
Parents looking for children’s Tylenol, ibuprofen find empty shelves
Demand from waves of RSV, flu and covid are causing sporadic shortages of children' drugs like Ibuprofen and Tylenol for some hospitals and retail stores.
-
PublishedNovember 20, 2022
RSV, flu, covid and staffing shortages push some hospitals to capacity
The combination of a swarm of respiratory illnesses, staffing shortages and nursing home closures has sparked the state of distress visited upon the already overburdened health-care system.
-
PublishedNovember 4, 2022
U.S. flu season off to a fast start as other viruses spread
Reports of flu are already high in 17 states, and the hospitalization rate hasn’t been this high this early since the 2009 swine flu pandemic.
-
PublishedOctober 10, 2022
For decades, failure in hunt for vaccine for child respiratory virus. Now, success.
Two RSV vaccines, one developed by pharmaceutical giant GSK and another from Pfizer, have protected older adults in large-scale trials in recent months.